BSE: 532843 FORTIS NSE

FORTIS HEALTHCARE LTD (532843) — Latest Corporate Announcements

₹755.6 ₹-1.65 (-0.22%)

Market Cap ₹57,044.64 Cr

P/E Ratio 52.44

52W Range ₹745.2 – ₹1104.3

Corporate Actions & Regulatory Filings

Financial Results (Quarterly & Annual)

Quarter / Period	Meeting / Outcome Date	Status	Filing Details
Quarter Ended 30-Jun-2026 (Q1 FY27) (STD & CONSOL)	06-Aug-2026	Declared	To consider and approve the Un-audited financial results (standalone & Consolidated) for the quarter ended Jun 30, 2026
Year Ended 31-Mar-2026 (Q4 FY26)	22-May-2026	Declared	To consider and approve the financial results for the period ended March 31, 2026 and recommendation of Final Dividend for the year ended March 31, 2026.
Quarter Ended 31-Dec-2025 (Q3 FY26)	13-Feb-2026	Declared	To consider and approve the financial results for the period ended December 31, 2025
Quarter Ended 30-Sep-2025 (Q2 FY26)	11-Nov-2025	Declared	To consider and approve the Un - Audited financial results for the period ended September 30, 2025
Quarter Ended 30-Jun-2025 (Q1 FY26)	06-Aug-2025	Declared	To consider and approve the financial results for the period ended Jun 30, 2025 and Alteration of rights of debenture holders/ matters affecting the rights and interests of debenture holders of the existing 1,55,000 (One lac and fifty-five thousand) listed, senior, secured, rated, redeemable Non-Convertible Debenture, each having a face value of INR 1,00,000/- (Indian Rupees One lac) and an aggregate value of up to INR 1550,00,00,000/- (Indian Rupees One Thousand Five Hundred and Fifty Crores only)
Year Ended 31-Mar-2025 (Q4 FY25)	20-May-2025	Declared	To consider and approve the financial results for the period ended March 31, 2025 and dividend
Quarter Ended 31-Dec-2024 (Q3 FY25)	07-Feb-2025	Declared	To consider and approve the financial results for the period ended December 31, 2024
Quarter Ended 30-Sep-2024 (Q2 FY25)	08-Nov-2024	Declared	To consider and approve the financial results for the period ended September 30, 2024
Quarter Ended 30-Jun-2024 (Q1 FY25)	06-Aug-2024	Declared	To consider and approve the financial results for the period ended Jun 30, 2024
Year Ended 31-Mar-2024 (Q4 FY24)	23-May-2024	Declared	Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Thursday, May 23, 2024, inter-alia, to: a) consider and approve audited financial results of the Company for the quarter and financial year ended March 31, 2024; and b) consider and recommend final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2024. Further, in continuation to our letter ref. FHL/SEC/2023-24 dated March 27, 2024 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till May 25, 2024.
Quarter Ended 31-Dec-2023 (Q3 FY24)	07-Feb-2024	Declared	To consider and approve the financial results for the period ended December 31, 2023
Quarter Ended 30-Sep-2023 (Q2 FY24)	10-Nov-2023	Declared	Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Friday, November 10, 2023 to, inter-alia, consider and approve un-audited financial results for the quarter and period ended September 30, 2023.Further, in continuation to our letter ref. FHL/SEC/2023-24 dated September 29, 2023 captioned Closure of Trading Window , it is hereby informed that the trading window of the Company for dealing in securities of the Company will remain closed till November 12, 2023.

Track Related Peer Equities

RELIANCE Track Reliance Industries Ltd Filings → TCS Track Tata Consultancy Services Ltd Filings → HDFCBANK Track HDFC Bank Ltd Filings → INFY Track Infosys Ltd Filings →

Related Research Guides & Regulatory Playbooks

SEBI LODR Regulation 30 Material Disclosures, Timelines & Filing Rules → Results Calendar Guide Earnings Dates, Board Notices & LODR Reg 33 → Shareholding Patterns Promoter Staking, Pledging & FII/DII Reg 31 → Insider Trading & PIT Trading Window Closures & Promoter Filings →

Frequently Asked Questions about FORTIS HEALTHCARE LTD BSE Disclosures

What is the latest BSE announcement by FORTIS HEALTHCARE LTD?

The latest BSE disclosure by FORTIS HEALTHCARE LTD (FORTIS), filed on 2026-10-13T11:14:40, is: "Fortis Healthcare Ltd - 532843 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018". Bsenexus tracks every official filing for FORTIS HEALTHCARE LTD with AI-powered summaries on its announcements feed.

When is FORTIS HEALTHCARE LTD's next board meeting?

No upcoming board meeting is currently tracked for FORTIS HEALTHCARE LTD. Companies disclose meeting intimations under SEBI LODR, and scheduled dates appear on the Bsenexus Results Calendar.

When does FORTIS HEALTHCARE LTD declare quarterly results?

Under SEBI (LODR) Regulation 33, listed companies submit quarterly unaudited results within 45 days of the quarter ending, and annual audited figures within 60 days. FORTIS HEALTHCARE LTD's recent results history is tabulated above. Track scheduled board meetings on the Bsenexus Results Calendar.

Track FORTIS HEALTHCARE LTD Announcements on Bsenexus Live Terminal →